Virtu Financial LLC Co Diagnostics, Inc. Transaction History

Virtu Financial LLC

$1.79 Billion
Q3 2025

A detailed history of Virtu Financial LLC transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 126,524 shares of CODX stock, worth $43,018. This represents 0.0% of its overall portfolio holdings.

Number of Shares

126,524

Previous 25,623 393.79%

Holding current value

$43,018

Previous $7,000 528.57%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$0.24 - $0.44 $24,216 - $44,396	100,901 Added 393.79%	126,524 $44,000
Q2 2025 Aug 12, 2025	SELL	$0.23 - $0.38 $6,581 - $10,873	-28,615 Reduced 52.76%	25,623 $7,000
Q1 2025 May 12, 2025	BUY	$0.31 - $1.0 $16,813 - $54,238	54,238 New	54,238 $17,000
Q3 2024 Nov 20, 2024	SELL	$1.02 - $1.75 $17,217 - $29,540	-16,880 Reduced 60.48%	11,029 $14,000
Q2 2024 Aug 09, 2024	BUY	$1.01 - $1.7 $28,188 - $47,445	27,909 New	27,909 $35,000
Q1 2023 May 01, 2023	SELL	$1.39 - $3.24 $83 - $194	-60 Reduced 0.38%	15,743 $23,000
Q4 2022 Feb 15, 2023	BUY	$2.32 - $3.68 $36,662 - $58,155	15,803 New	15,803 $40,000
Q2 2021 Sep 17, 2021	SELL	$7.16 - $9.56 $356,539 - $476,049	-49,796 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$8.52 - $19.21 $203,074 - $457,870	23,835 Added 91.81%	49,796 $475,000
Q4 2020 Feb 24, 2021	BUY	$9.3 - $15.19 $241,437 - $394,347	25,961 New	25,961 $241,000
Q3 2020 Dec 11, 2020	SELL	$8.24 - $30.8 $565,049 - $2.11 Million	-68,574 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$7.46 - $23.42 $231,759 - $727,589	31,067 Added 82.83%	68,574 $1.33 Million
Q4 2019 Feb 04, 2020	BUY	$0.88 - $1.12 $33,006 - $42,007	37,507 New	37,507 $34,000

Others Institutions Holding CODX

# of Institutions

Shares Held

5.57M

Call Options Held

58K

Put Options Held

31.8K

View Full List

About Co-Diagnostics, Inc.

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $11.5M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

More about CODX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account

Virtu Financial LLC Co Diagnostics, Inc. Transaction History